NEJM study on the effect of mutation order in MPNs

February 12, 2015

The order in which someone with an MPN acquires a genetic mutation may effect their prognosis, says an article published today in the New England Journal of Medicine. Researchers from the U.K. were able to determine the order in which people with myeloproliferative neoplasms acquired the TET2 and JAK2 mutations, which influenced response to therapy, the biology of stem and progenitor cells and clonal evolution.

Click here for NEJM

Click here for an additional synopsis of the findings

Receive updates on the latest MPN news & events.

Find out ways you can help support MPN patients and researchers.

x

NEVER MISS AN UPDATE

Get free, timely information on living with an MPN.

Subscribe